FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 08:26:25 2024-06-06 am EDT | ||
| 6.38 EUR | +0.16% |
|
| Current month | +7.42% | ||
| 1 month | -11.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 6.38 | +0.16% |
| 24-06-05 | 6.37 | -0.47% |
| 24-06-04 | 6.4 | +3.73% |
| 24-06-03 | 6.17 | +4.05% |
| 24-05-31 | 5.93 | +1.72% |
Real-time BOERSE MUENCHEN
Last update June 06, 2024 at 08:26 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GK3H4T |
| ISIN | DE000GK3H4T2 |
| Date issued | 2022-04-14 |
| Strike | 245.9 $ |
| Maturity | Unlimited |
| Parity | 9.14 : 1 |
| Emission price | 10.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.02 € |
|---|---|
| Lowest since issue | 2.246 € |
| Spread | 0.07 € |
| Spread % | 1.10% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.89%
- Stock Market
- Certificates
- Certificat
